May 22, 2013 | sbwire.com
New Pharmaceuticals market report from Global Markets Direct: "Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2013" ) -- 05/22/2013 -- Global Markets Direct's,...
Read more...
Fast Market Research Androgen-Independent Castration Refractory Hormone Resistant Metastatic Prostate pipeline Cancer
May 22, 2013 | auntminnie.com
May 22, 2013 -- Radiation oncology firm Accuray said that a large study using its CyberKnife robotic radiosurgery system validated use of the technology for prostate cancer treatment. To view the remainder of this article, and...
Read more...
CyberKnife Accuray study prostate intermediate-risk patient radiation treatment
May 22, 2013 | genomeweb.com
A systems biology-based analysis of postmortem brain samples from individuals with late-onset Alzheimer's disease suggests a microglial cell and immune function-related network may contribute to the disease. In Cell,...
Read more...
chromoplexy cancer cell punctuated late-onset prostate rearrangement sample postmortem researcher genomic individual genome function-related GWDN brain tumor-normal Alzheimer dementia-free study disease microglial biology-based tumor gene translocations microglia immune
May 21, 2013 | nih.gov
Men who get an older and less costly form of radiation after their cancerous prostates are removed fare just as well as men who get a new and expensive type of radiation, according to a new study. Source: Reuters Health Related...
Read more...
IMRT radiation prostate CRT patient cancer Chen study
May 22, 2013 | cancerlive.net
After more than a decade of work, UC Irvine chemists have created a way to clearly identify clinically usable markers for prostate cancer in urine, meaning that the disease could be detected far sooner, with greater accuracy...
Read more...
cancer urine prostate Irvine UC inexpensive detect test receptor marker phage Weiss 130522095819.htm
May 22, 2013 | finanznachrichten.de
BOTHELL, Wash. and VANCOUVER, British Columbia, May 22, 2013 /PRNewswire/ --OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI), a leader in the development of novel therapeutics to target mechanisms of treatment resistance in...
Read more...
OncoGenex OGX-427 cancer trial ASCO ORCA custirsen clinical resistance Phase treatment metastatic Hsp27 clusterin
May 22, 2013 | finanznachrichten.de
LOS ANGELESand NEW YORK, May 22, 2013 /PRNewswire-USNewswire/ --The Safeway Foundation and Stand Up To Cancer (SU2C), a program of the Entertainment Industry Foundation (EIF), have teamed up to develop a print, radio and...
Read more...
Safeway SU2C prostate cancer Foundation Marcia Cross PSA Stand Up EIF research
May 22, 2013 | gnom.es
NEW YORK , May 22, 2013 /NEWS.GNOM.ES/ — Reportlinker.com announces that a new market research report is available in its catalogue: Consensus Outlook: Prostate Cancer – Competition intensifies in race to the top...
Read more...
forecast prostate Cancer consensus FirstWord Outlook Therapy product intensify Trends event sale data unrivalled
May 21, 2013 | ivillage.com
For older patients with hypertension, heart failure, different problems will likely cause death, study finds TUESDAY, May 21 (HealthDay News) -- Aggressive treatment for prostate cancer may not be warranted for many older...
Read more...
All similar articles: 139 »
prostate cancer Daskivich treatment risk 14-year dying study patient
May 22, 2013 | bio-medicine.org
BUFFALO, N.Y. , May 22, 2013 /- Empire Genomics announced today it has acquired an exclusive license for a patent pending novel genomic biomarker from Cornell University for use in developing a molecular diagnostic test that...
Read more...
NEPC Genomics diagnosing empire prostate novel PCA license Cornell neuroendocrine molecular patient Commercialization cancer CCTEC
May 22, 2013 | prostate.net
Sipuleucel-T vs Radium-223 for Prostate Cancer Sipuleucel-T vs radium-223 compares two medications for late-stage castration-resistant prostate cancer. Sipuleucel-T has been available since April 2010, but now with the FDA...
Read more...
Sipuleucel-T Radium-223 vs Prostate cancer medication patient
May 21, 2013 | finance.yahoo.com
LYON, France -- EDAP TMS SA , a global leader in therapeutic ultrasound, announced that it has entered into definitive agreements with certain institutional investors for a registered direct placement ...
Read more...
EDAP TMS Ablatherm-HIFU HIFU treatment SA Wainwright&Co offering registered H.C. direct prostate
May 20, 2013 | genomeweb.com
Full-text access for registered users only. Existing users Advances in Single-Cell Genomics: Live Cell RNA and Circulating miRNA Detection Sponsor: EMD Millipore Data presented in this webinar illustrates the value of live cell...
Read more...
Heliconius variation miRNAs regulatory sequencing protein transcriptome adaptive plasma prostate butterfly Pearlman quantification phenotype gene cancer cell co-mimicking pattern-associated alteration-based RNA Sponsor
May 20, 2013 | nature.com
1Department of Medicine, University of Melbourne Austin Health, Heidelberg, Victoria 3084, Australia Correspondence: Professor M Grossmann, In a pivotal phase 3 randomized controlled trial, Hussain et al. tested the hypothesis...
Read more...
ADT intermittent prostate therapy continuous metastatic et al. trial survival cancer ADT-associated ml−1
May 21, 2013 | ro-journal.com
Alan J Katz, Michael Santoro, Fred Diblasio and Richard Ashley Background Stereotactic body radiotherapy (SBRT) may yield disease control for prostate cancer in a brief, hypofractionated treatment regimen without increasing...
Read more...
Alan J Katz 36.25?Gy Stereotactic 35?Gy patient prostate radiotherapy toxicity urinary QOL Grade cancer dose rectal disease biochemical SBRT PSA
May 19, 2013 | asianscientist.com
AsianScientist (May 20, 2013) – The Prostate Cancer Foundation (PCF) has funded two new young investigators in China to lead innovative prostate cancer research projects within the country. The PCF China Young Investigator...
Read more...
PCF prostate cancer EMI1 investigator China AsianScientist progression anti-inflammatory award young
May 21, 2013 | seekingalpha.com
Executives David T. Hung - Chief Executive Officer, President and Executive Director Analysts Matthew Roden - UBS Investment Bank, Research Division Medivation, Inc. UBS Global Healthcare Conference May 20, 2013 1:00 PM ET...
Read more...
XTANDI patient pre-chemo ZYTIGA trial PREVAIL Medivation post-chemo prostate placebo indiscernible drug Casodex Lupron transcript Astellas cancer survival
May 21, 2013 | healthcanal.com
Essential to jerk seasoning, allspice is known for flavoring Jamaican and other cuisines around the world with a blend of cinnamon, cloves, nutmeg and pepper but, according to a new study by Miller School researchers, the...
Read more...
allspice Lokeshwar Ericifolin prostate cancer Nagarajarao anticancer compound Jamaican
May 20, 2013 | cbslocal.com
ST. LOUIS (KMOX) - Millions of men are now being told not to undergo routine screening for prostate cancer. The American Urological Association now supports new guidelines which state routine screening is no longer recommended...
Read more...
screening prostate Saddiqui guideline cancer benefit routine over-diagnosing
May 20, 2013 | cancernetwork.com
By Anna Azvolinsky, PhD1 | May 20, 2013 1Freelance Science Writer and Cancer Network Contributor. Follow Her on Twitter A large, 20-year prospective study shows that men aged 50 or older engaged in plenty of cardiovascular...
Read more...
Anna Azvolinsky cancer fitness Lakoski lung study staying prostate cardiorespiratory risk colorectal fit cardiovascular
May 20, 2013 | eurekalert.org
Below is information about articles being published in the May 21 issue of Annals of Internal Medicine. The information is not intended to substitute for the full articles as a source of information. Annals of Internal Medicine...
Read more...
All similar articles: 285 »
embargoed DSM-5 prostate cancer diagnosis Internal Medicine comorbid DSM-IV author www.annals.org disorder DSM-III intermediate-risk Collom comorbidity
May 20, 2013 | newsfix.ca
A study shows that men over 80 can tolerate radiation therapy as well as their younger counterparts. Many older men develop prostate cancer and it’s sometimes hard to know how best to treat them. They may well die of some other...
Read more...
All similar articles: 579 »
Robert Cervin radiotherapy prostate cancer patient radiation old elderly therapy
May 21, 2013 | theconversation.edu.au
Following Hollywood actress Angelina Jolie’s revelation last week that she’d undergone a double mastectomy to prevent breast cancer, it has emerged that a 53-year-old man had his prostate removed after abnormal cells were...
Read more...
All similar articles: 210 »
cancer BRCA gene breast BRCA2 BRCA1 NHS testing ovarian genetic prostate risk surgery woman
May 19, 2013 | ibtimes.co.uk
Angelina Jolie has revealed she underwent a double masectomy when tests revealed genes associated with breast cancer A 53-year-old British father has become the first man to have his prostate removed because tests revealed he...
Read more...
All similar articles: 816 »
Jolie prostate cancer gene After reveal BRCA2 BRCA test surgeon breast gland Angelina remove masectomy associate cell carry
May 21, 2013 | finanznachrichten.de
RICHLAND, Wash., May 21, 2013 /PRNewswire/ --IsoRay, Inc. (AMEX: ISR), (http://www.isoray.com/), announced today that it has entered into an exclusive international distribution agreement with IASIS Medical for the sale of...
Read more...
IsoRay cancer Cesium-131 Cs-131 brachytherapy product prostate
May 19, 2013 | forbiddennews.info
1 0 Eating a lot of red and processed meats is unhealthy for several reasons, one of which is it may increase your risk of prostate cancer. Studies show that men who ate the most red meat were 12 percent more likely to develop...
Read more...
prostate PFOA food meat cancer health tomato popcorn chemical dairy 10-worst-foods-for-prostate-health BPA eat calcium microwave
May 20, 2013 | prostate.net
Xofigo Compared to Xtandi Xofigo compared to Xtandi means that men with prostate cancer have another treatment option to consider. The Food and Drug Administration (FDA) approved a new medication, Xofigo (radium-223...
Read more...
Xtandi Xofigo prostate cancer medication
May 21, 2013 | inserbia.info
LONDON – A British businessman has had his prostate removed after he discovered he was carrying a “faulty” gene that increased his chances of getting prostate cancer, reported VoR. The 53-year-old man, whose name is not...
Read more...
M. Stoiljkovic prostate faulty gene businessman British remove cancer wakpaper.com VoR
May 19, 2013 | thisisspain.info
“Positively Pink” & “Positively Blue” Screening Programmes! As you will know Positively Pink is a Mijas based charity and its sole purpose is to raise the necessary funds to provide education, support and a FREE breast...
Read more...
Positively screening cancer program Pink Clinica charity Mijas FREE Sol Medicare prostate Costa
May 21, 2013 | bz.cm
89.3 KPCCOlder Prostate Cancer Patients with Other Underlying Health Problems Ought to ...Newswise (press release)Newswise — Older prostate cancer patients with other underlying health conditions should think twice before...
Read more...
Ought to Newswise Underlying Prostate Problems Patients Cancer Other Health old press Older